Australian research has shown that induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells can help regenerate damaged lung tissue in an experimental model of asthma. The study found that the stem cells could tackle asthma on multiple levels – reducing inflammation, reversing signs of airway remodelling, and normalising airway hyperresponsiveness. The researchers said mesenchymal stem cells ...
Already a member?
Enter your email to keep reading.